Propriedade intelectual e pandemia de Covid-19: um estudo de caso da relação jurídica entre a Fiocruz e a AstraZeneca
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Based on the analysis of the complex agreement signed between
Fiocruz/Bio-Manguinhos and Astranezeca for the production of the Covid-19 vaccine,
this research aimed to better understand the limits of the current regulatory system of
intellectual property in a situation of health crisis such as the Covid-19 pandemic. It is
an qualitative research and a empirical single case study carried out from primary
and secondary sources, guided by a critical analysis of intellectual property. Even
considering the emergence of the pandemic, it was found that the alternatives
proposals to the system were unsuccessful and the agreement between Fiocruz and
Astrazeneca established more accordance than rupture with the current Brazilian
intellectual property system. It was observed that the agreement could be seen as an
extension of this system, as it followed the rules laid down in national and
international legislation, that is, there was no adaptation and even less rupture with
the pre-established rules.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

